The Rounds Table

Send us Fan Mail   Is October making you overtired and moody? Tune in this week as Dr. Paxton Bach, resident in General Internal Medicine at UBC, and Kieran discuss two tantalizing studies! The SAVE Clinical Trial is the largest ever to study the effect of CPAP on prevention of cardiovascular outcomes and death in patients with obstructive sleep ... The post Moody & unSAVEd – CPAP for Preventi...

Send us Fan Mail We’re back and better than ever with a NEW host! This season, Kieran Quinn takes the reigns and is excited to bring you the latest and greatest in the world of emerging clinical evidence. Along outgoing host Amol Verma, the two hosts discuss two studies: Just how dangerous are opioids in the treatment of chronic pain ... The post REPLAY – Drugs on the Brain: Opining on Opioid-Indu...

Send us Fan Mail   Bugs, drugs, and optimal duration for antibiotic therapy? New frontiers in HIV treatment? Listen this week as Kieran and Jay Spiegel, a resident in General Internal Medicine in Toronto, discuss two studies: It’s hard to remember what the right drug is to treat a certain bug, let alone the correct duration of therapy. Further, ... The post Bugs & Drugs – Duration of Antibioti...

Send us Fan Mail This week Kieran and Dr. Fraser Pollard, a Family Physician in Trenton, Ontario, discuss two studies: Using long acting beta agonists (LABAs) safely and appropriately in the management of asthma is widely debated, with evidence suggesting a potential risk of serious asthma-related events associated with the use of LABAs. But is the potential risk warranted? ... The post Dazed and...

Send us Fan Mail We’re back and better than ever with a NEW host! This season, Kieran Quinn takes the reigns and is excited to bring you the latest and greatest in the world of emerging clinical evidence. Along outgoing host Amol Verma, the two hosts discuss two studies: Just how dangerous are opioids in the treatment of chronic pain ... The post Drugs on the Brain: Opining on Opioid-Induced Death...

Send us Fan Mail This week, Amol and Dr. Kieran Quinn, both general internal medicine residents at the University of Toronto, discuss two studies: Where do people die? What types of care do they utilize at the end of life? A retrospective cohort study of people who died with cancer in seven developed countries evaluated the number of deaths ... The post Summer Replay – Valued Care: End of Life Car...

Send us Fan Mail This week, Amol, resident in General Internal Medicine at University of Toronto, and Mike Fralick, chief medical resident at St. Michael’s Hospital in Toronto, talk about 2 blood pressure studies: A meta-analysis and systematic review found that more intensive blood pressure lowering was associated with improved cardiovascular outcomes and albuminuria. Amol discusses the trade-off...

Send us Fan Mail This week Amol and Nathan discuss two studies: A multi-centre, prospective study evaluated the physical and mental health status of caregivers for patients discharged from the intensive care unit (ICU). Using hospital data and self-administered questionnaires, the study found most caregivers of critically ill patients are at high risk for depression, anxiety and poor mental health...

Send us Fan Mail This week, Amol and Kieran discuss two studies: How can we prevent readmission? An observational study of 1000 general internal medicine patients from 12 United States academic medical centres found that 26.9% of readmissions were potentially preventable. Key factors associated with potential preventability included decision making in the emergency department, lack of information...

Send us Fan Mail This week, Amol talks about new antithrombotic therapy guidelines and using low calorie diet for diabetes remission. The American College of Chest Physicians issued new antithrombotic guidelines for the treatment of venous thromboembolism in February 2016. Amol highlights five updates in the guidelines, and discusses the evidence behind each recommendation. Diabetes has long been...

Send us Fan Mail This is our final episode of the year! We want to thank everyone who has hosted or contributed to the podcast, and of course you – our dear listeners – for tuning in every week. We will be re-playing some of our favourite past episodes, and bringing you brand new content in the fall. Good ... The post Season Finale: All ‘Good Stuff’ Must Come to an End appeared first on Healthy De...

Send us Fan Mail This week, Amol and Rebecca discuss a recent study and an updated recommendation: A multi-centre, randomized control trial (the LEADER trial) examined the cardiovascular effect of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue. Patients with type 2 diabetes and high cardiovascular risk were randomly assigned to receive either standard of care plus liraglutide or standard...

Send us Fan Mail This week, Amol and Kieran discuss two studies: How can we prevent readmission? An observational study of 1000 general internal medicine patients from 12 United States academic medical centres found that 26.9% of readmissions were potentially preventable. Key factors associated with potential preventability included decision making in the emergency department, lack of information...

Send us Fan Mail This week Amol and Nathan discuss two studies: A multi-centre, prospective study evaluated the physical and mental health status of caregivers for patients discharged from the intensive care unit (ICU). Using hospital data and self-administered questionnaires, the study found most caregivers of critically ill patients are at high risk for depression, anxiety and poor mental health...

Send us Fan Mail This week, Amol talks about new antithrombotic therapy guidelines and using low calorie diet for diabetes remission. The American College of Chest Physicians issued new antithrombotic guidelines for the treatment of venous thromboembolism in February 2016. Amol highlights five updates in the guidelines, and discusses the evidence behind each recommendation. Diabetes has long been...

Send us Fan Mail This week, Amol and Janice, staff internist at Mount Sinai Hospital, discuss two studies: A randomized trial asked whether diluted apple juice works just as well as oral rehydration therapy in treating minimal dehydration in children with gastroenteritis. Children 6 to 60 months presenting to the emergency department were randomized to half-strength apple juice or ... The post New...

Send us Fan Mail This week, Amol and Dr. Kieran Quinn, both general internal medicine residents at the University of Toronto, discuss two studies: Where do people die? What types of care do they utilize at the end of life? A retrospective cohort study of people who died with cancer in seven developed countries evaluated the number of deaths ... The post Valued Care: End of Life Care and Early Tren...

Send us Fan Mail This week, we are replaying one of our favourite past episodes. Originally aired on February 12, 2016, Amol, general internal medicine resident at the University of Toronto, and Fahad, staff internist at St. Michael’s hospital in Toronto, discuss 3 papers: Where do physicians die? What is the intensity of the care they receive at the ... The post Replay: How Physicians Die and Fro...

Send us Fan Mail What is the risk of adverse events after a transient ischemic attack (TIA)? While older studies tell us that the risk of stroke or acute coronary syndrome after a TIA is high in the first 3 months, does this hold true today? An international TIA Registry tried to answer this question by characterizing TIA and ... The post Talking TIAs: Physician Assisted Death in Canada and a Tran...

Send us Fan Mail This week, Amol and Nathan discuss two high profile papers: Authors from the Centres for Disease Control and Prevention (CDC) recently published a report concluding that there is a causal relationship between Zika virus infection and a syndrome of birth defects, notably microcephaly. Nathan and Amol review the evidence the authors presented for this causality, ... The post Blockbu...

Send us Fan Mail This week, Amol and Reena, internist at St. Michael’s hospital in Toronto, discuss the HOPE-3 trial. HOPE-3 is a 2-by-2 double blind randomized placebo controlled trial, which found that statins were effective in preventing cardiovascular events in intermediate risk patients but anti-hypertensives were not. While candesartan and hydrochlorothiazide were not superior to placebo, ro...

Send us Fan Mail This week, Amol and his co-host Reena, general internist at St. Michael’s Hospital in Toronto, discuss two recent papers on depression: What is the risk of cardiovascular outcomes in patients using antidepressants? A cohort study of patients age 20 to 64 found no evidence that selective serotonin reuptake inhibitors (SSRIs) are associated with increased cardiovascular ... The post...

Send us Fan Mail This week, Amol and Nathan discuss breast cancer and colorectal cancer: Two randomized control trials compared the aromatase inhibitor anastrozole to tamoxifen as adjuvant hormone therapy for postmenopausal women with ductal carcinoma in situ. Both trials were double blind and multi-centred, with one trial (NSABP B-35) enrolling North American patients and the other (IBIS-II DCIS)...

Send us Fan Mail This week, we debut a new format at the Rounds Table. Amol reviews articles published from the latest edition of four journals: Journal of the American Medical Association (JAMA), the Lancet, Annals of Internal Medicine and the New England Journal of Medicine (NEJM). Tune in to hear the latest medical findings, including mindfulness for back ... The post Headlines and Highlights:...

Send us Fan Mail This week, Amol discusses contrast induced nephropathy. At an overall reported incidence of 10%, contrast induced nephropathy leads to worse clinical outcomes and double the rate of mortality. A systematic review and meta-analysis on the effectiveness of prevention strategies found that there is no strong evidence for any intervention beyond volume expansion with saline. N-acetyl...